Sector Chart Merck & Co., Inc.

MRK

US58933Y1055

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Pharmaceuticals

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
MERCK & CO., INC.	246B
ELI LILLY AND COMPANY	904B
JOHNSON & JOHNSON	506B
ABBVIE INC.	396B
ROCHE HOLDING AG	342B
ASTRAZENECA PLC	283B

Real-time Estimate Cboe BZX Other stock markets 10:49:55 2025-12-12 EST			5-day change	1st Jan Change
100.46 ^USD	+1.46%		+0.14%	+0.38%

10:21am	Merck Receives Positive EU Chmp Opinion for Expanded Use of Winrevair?? (Sotatercept) in Adults with Pulmonary Arterial Hypertension (Pah, Who* Group 1 Pulmonary Hypertension)	CI
09:37am	Merck Says Europe's CHMP Grants 'Positive Opinion' for Winrevair Expansion for Pulminary Arterial Hypertension	MT

Sector Chart Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Sector Other Pharmaceuticals